Post by
cashflow98 on May 06, 2016 10:44am
Amber Kanwar's 'deep' dive into CXR pricing
https://www.bnn.ca/News/2016/5/6/Concordia-Healthcare-Diving-deep-into-claims-of-sky-high-prices.aspx
Comment by
Marcel7 on May 06, 2016 10:53am
Well there is this: "In fact, since Concordia took ownership in October, the price of the pink eye drug, Fucithalmic, is actually unchanged. The price increased 50 per cent right before Concordia took ownership." Marcel
Comment by
Pj1958 on May 06, 2016 11:01am
LETTUCE AND COMPANY.... And was ridiculed for saying that the price hikes were done by AMCo prior to CXR buying them out....OF COURSE IT MATTERS WHO RAISES THE PRICES. CXR only raised prices on 2 drugs since the buyout , and they shouldn't be smeared by the short and distort gang for price increases that they are not responsible for.
Comment by
Lattice on May 06, 2016 11:15am
This post has been removed in accordance with Community Policy
Comment by
Pj1958 on May 06, 2016 12:02pm
LETTUCE.....wrong again.... They did not raise 59%... I don't know where you're reading skills were acquired... But they only increased the price of 2 medications since they bought AMCo's 160 drugs. 30% on each. You may want to read the article slowly , the other raises were done prior to the purchase. Short and distort again.
Comment by
Lattice on May 06, 2016 12:26pm
This post has been removed in accordance with Community Policy
Comment by
digitel on May 06, 2016 11:03am
This post has been removed in accordance with Community Policy
Comment by
Lesalpes29 on May 06, 2016 11:10am
Very good analysis craby. Ignore list is your place now!